UnitedHealth Group Incorporated
NYSEUnitedHealth Group has extended its slide to $375.93, and the options market has now reached its most defensive posture in a full year — a new record that eclipses even last week's reported high. The clearest signal this week is in options. The put/call ratio climbed to 0.9423 on Tuesday, a fresh 52-week high and above the prior peak of 0.9383 reported just the session before. At…
UNH cost to borrow surges to 0.49%, up 114% in one week as shorts cover positions amid legal headwinds and margin pressures.
A new long-form analysis for UNH this week — anomalies vs the company's own history, peer comparisons, news context, and the full data picture. Premium subscribers only.
Read on ORTEX →Sign up for premiumUnitedHealth Group has extended its slide to $375.93, and the options market has now reached its most defensive posture in a full year — a new record that eclipses even last week's reported high. The clearest signal…
Snapshot as of 20 Sept 2026
UnitedHealth Group ends the week essentially unchanged, but a quiet surface masks a slow-motion compression story: the stock is still trading at a steep discount to Street targets, multiples have drifted lower, and the…
UnitedHealth Group has steadied this week, but the gap between where the stock trades and where the Street thinks it should trade remains one of the more striking dislocations in large-cap healthcare. The stock closed…
UnitedHealth Group is pushing further from its post-earnings base, but the options market still hasn't called off its defensive posture — and now the Street is playing catch-up with a fresh round of target upgrades…
UnitedHealth Group has cleared its Q2 print and the Street wasted no time responding — targets moved sharply higher on the day of results, but the stock gave back ground anyway, closing Tuesday at $425.19, down 0.9% on…
UnitedHealth Group arrives at its July 16 Q2 earnings report with one of the most unified analyst setups in the sector, a stock that has clawed back most of its April collapse — and options traders who still haven't…
UnitedHealth Group enters its July 14 Q2 print having given back a fraction of June's recovery — the stock closed Thursday at $424.62, down 1.6% on the day but still up nearly 3% on the month and roughly 42% above…
UnitedHealth Group closed Tuesday at $428.19 — back above the mean analyst price target of $418 and up 3% on the week — with six days left before Q2 results reshape the entire narrative. The shift from the June 30…
UnitedHealth Group has given back ground in the final session of June, slipping below the mean analyst price target for the first time since last week's sharp rally reversed that condition — setting up a charged…
UnitedHealth Group has clawed back above its mean analyst price target this week, reversing last week's slip below consensus, while options traders continue to hedge at near-record levels ahead of Q2 earnings on July…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for UNH — free to start on ORTEX.
Sign up for free →Open UNH on ORTEX